Grazoprevir
| CAS No. | 1350514-68-9 |
|---|---|
| MDL No. | N/A |
| MF | C38H50N6O9S |
| MW | 766.90 |
| InChI Key | OBMNJSNZOWALQB-NCQNOWPTSA-N |
| CAS No. | 1350514-68-9 |
|---|---|
| MDL No. | N/A |
| MF | C38H50N6O9S |
| MW | 766.90 |
| InChI Key | OBMNJSNZOWALQB-NCQNOWPTSA-N |
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| - | - | On Request | On Request | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Grazoprevir is an azamacrocyclic hepatitis C protease inhibitor used in combination with elbasvir (brand name Zepatier) to treat chronic HCV genotypes 1 or 4 infection in adults. It functions as an antiviral, hepatoprotective agent, and protease inhibitor. Chemically, it is an azamacrocycle, carbamate ester, lactam, aromatic ether, cyclopropane, N-sulfonylcarboxamide, and quinoxaline derivative.
| CAS No. | 1350514-68-9 |
|---|---|
| Product Name | Grazoprevir |